Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-04

Clinical Trial Update: Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update on Leflunomide for steroid-dependent chronic graft-versus-host disease. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leflunomide (Leflunomide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Chronic Graft Versus Host Disease, Steroid Refractory Graft Versus Host Disease | Phase 1 | Status: ACTIVE_NOT_RECRUITING